Vironika, LLC Information

Vironika, LLC, is an early stage drug discovery company dedicated to developing novel drugs to block deadly tumor viruses from forming cancers. Unlike any other existing treatments, Vironika’s technology platform include proprietary small molecule inhibitors that target viral proteins which will eliminate tumor viruses in their latent hidden forms.

Website	http://www.vironika.com
Revenue	$6 million
Employees	1 (0 on RocketReach)
Founded	2007
Address	100 E Lancaster Ave Limr Rm 133, Wynnewood, Pennsylvania 19096, US
Phone	+1 610-896-0580
Industry	Biotechnology Research, Business Services General, Drug Discovery, Business Services
Keywords	Drug Discovery, Drug Development, Cancer Treatment, Cancer Research, Oncology, Molecular Medicine, Viral Infections, Small Molecule Inhibitors, Therapeutic Agents, Oncolytic Viruses, Antiviral Therapeutics, Immunotherapy, Novel Therapeutics, Precision Medicine, Pharmaceutical Research, Biopharma, Biotechnology, Clinical Trials
Competitors	Innovation Catalyst Partners Inc, Xyz Technologies Inc, Pinnacle Insights, Resource Dynamics, Innovative Solutions, Visionary Tech, Advanced Solutions, Foresight Dynamics, LLC, Inspired Technologies, Insight Partners +9 more* (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies